Early Diagnosis of Alzheimer's Disease Based on Resting-State Brain Networks and Deep Learning

Machine-learning models for Alzheimer's disease diagnosis using neuroimaging data: survey, reproducibility, and generalizability evaluation

Clinical diagnosis of Alzheimer's disease (AD) is usually made after symptoms such as short-term memory loss are exhibited, which minimizes the intervention and treatment options. The existing screening techniques cannot distinguish between stable MCI (sMCI) cases (i.e., patients who do not convert to AD for at least three years) and progressive MCI (pMCI) cases (i.e., patients who convert to AD in three years or sooner). Delayed diagnosis of AD also disproportionately affects underrepresented and socioeconomically disadvantaged populations. The significant positive impact of an early diagnosis solution for AD across diverse ethno-racial and demographic groups is well-known and recognized. While advancements in high-throughput technologies have enabled the generation of vast amounts of multimodal clinical, and neuroimaging datasets related to AD, most methods utilizing these data sets for diagnostic purposes have not found their way in clinical settings. To better understand the landscape, we surveyed the major preprocessing, data management, traditional machine-learning (ML), and deep learning (DL) techniques used for diagnosing AD using neuroimaging data such as structural magnetic resonance imaging (sMRI), functional magnetic resonance imaging (fMRI), and positron emission tomography (PET). Once we had a good understanding of the methods available, we conducted a study to assess the reproducibility and generalizability of open-source ML models. Our evaluation shows that existing models show reduced generalizability when different cohorts of the data modality are used while controlling other computational factors. The paper concludes with a discussion of major challenges that plague ML models for AD diagnosis and biomarker discovery.

Early detection and classification of Alzheimer's disease through data fusion of MRI and DTI images using the YOLOv11 neural network

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide, affecting over 55 million people globally, with numbers expected to rise dramatically. Early detection and classification of AD are crucial for improving patient outcomes and slowing disease progression. However, conventional diagnostic approaches often fail to provide accurate classification in the early stages. This paper proposes a novel approach using advanced computer-aided diagnostic (CAD) systems and the YOLOv11 neural network for early detection and classification of AD. The YOLOv11 model leverages its advanced object detection capabilities to simultaneously localize and classify AD-related biomarkers by integrating multimodal data fusion of T2-weighted MRI and DTI images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Regions of interest (ROIs) were selected and annotated based on known AD biomarkers, and the YOLOv11 model was trained to classify AD into four stages: Cognitively Normal (CN), Early Mild Cognitive Impairment (EMCI), Late Mild Cognitive Impairment (LMCI), and Mild Cognitive Impairment (MCI). The model achieved exceptional performance, with 93.6% precision, 91.6% recall, and 96.7% mAP50, demonstrating its ability to identify subtle biomarkers by combining MRI and DTI modalities. This work highlights the novelty of using YOLOv11 for simultaneous detection and classification, offering a promising strategy for early-stage AD diagnosis and classification.

Towards Clinical Diagnoses: Classifying Alzheimer's Disease Using Single fMRI, Small Datasets, and Transfer Learning

PURPOSE

Deep learning and functional magnetic resonance imaging (fMRI) are two unique methodologies that can be combined to diagnose Alzheimer's disease (AD). Multiple studies have harnessed these methods to diagnose AD with high accuracy. However, there are difficulties in adapting this research to real-world diagnoses. For example, the two key issues of data availability and model usability limit clinical applications. These two areas are concerned with problems of accessibility, generalizability, and methodology that may limit model adoption. For example, fMRI deep learning models require a large amount of training data, which is not widely available. Contemporary models are also not typically formatted for clinical data or created for use by non-specialized populations. In this study, we develop a deep-learning fMRI pipeline that addresses some of these issues.

METHOD

We use transfer learning to address problems with data availability. We also use semi-automated and single-image techniques (i.e., one fMRI volume per participant) to make a model that is usable for non-specialized populations. Our model was initially trained on 524 participants from the Autism Brain Imaging Data Exchange (ABIDE; Autism and controls). Our model was then transferred and fine-tuned to a small sample of 64 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI; AD and controls).

FINDINGS AND CONCLUSION

This transfer learning model achieved an AD classification accuracy of 77% and outperformed the same model without transfer learning by approximately 30%. Accordingly, our model showed that small AD samples can be accurately classified in a clinically friendly manner.

BPEN: Brain Posterior Evidential Network for trustworthy brain imaging analysis

The application of deep learning techniques to analyze brain functional magnetic resonance imaging (fMRI) data has led to significant advancements in identifying prospective biomarkers associated with various clinical phenotypes and neurological conditions. Despite these achievements, the aspect of prediction uncertainty has been relatively underexplored in brain fMRI data analysis. Accurate uncertainty estimation is essential for trustworthy learning, given the challenges associated with brain fMRI data acquisition and the potential diagnostic implications for patients. To address this gap, we introduce a novel posterior evidential network, named the Brain Posterior Evidential Network (BPEN), designed to capture both aleatoric and epistemic uncertainty in the analysis of brain fMRI data. We conducted comprehensive experiments using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and ADNI-depression (ADNI-D) cohorts, focusing on predictions for mild cognitive impairment (MCI) and depression across various diagnostic groups. Our experiments not only unequivocally demonstrate the superior predictive performance of our BPEN model compared to existing state-of-the-art methods but also underscore the importance of uncertainty estimation in predictive models.

Generative dynamical models for classification of rsfMRI data

The growing availability of large-scale neuroimaging datasets and user-friendly machine learning tools has led to a recent surge in studies that use fMRI data to predict psychological or behavioral variables. Many such studies classify fMRI data on the basis of static features, but fewer try to leverage brain dynamics for classification. Here, we pilot a generative, dynamical approach for classifying resting-state fMRI (rsfMRI) data. By fitting separate hidden Markov models to the classes in our training data and assigning class labels to test data based on their likelihood under those models, we are able to take advantage of dynamical patterns in the data without confronting the statistical limitations of some other dynamical approaches. Moreover, we demonstrate that hidden Markov models are able to successfully perform within-subject classification on the MyConnectome dataset solely on the basis of transition probabilities among their hidden states. On the other hand, individual Human Connectome Project subjects cannot be identified on the basis of hidden state transition probabilities alone-although a vector autoregressive model does achieve high performance. These results demonstrate a dynamical classification approach for rsfMRI data that shows promising performance, particularly for within-subject classification, and has the potential to afford greater interpretability than other approaches.

Recurrence quantification analysis of rs-fMRI data: A method to detect subtle changes in the TgF344-AD rat model

BACKGROUND AND OBJECTIVE

Alzheimer's disease (AD) is one of the leading causes of dementia, affecting the world's population at a growing rate. The preclinical stage of AD lasts over a decade, hence understanding AD-related early neuropathological effects on brain function at this stage facilitates early detection of the disease.

METHODS

Resting-state functional magnetic resonance imaging (rs-fMRI) has been a powerful tool for understanding brain function, and it has been widely used in AD research. In this study, we apply Recurrence Quantification Analysis (RQA) on rs-fMRI images of 4-months (4 m) and 6-months-old (6 m) TgF344-AD rats and WT littermates to identify changes related to the AD phenotype and aging. RQA has been focused on areas of the default mode-like network (DMLN) and was performed based on Recurrence Plots (RP). RP is a mathematical representation of any dynamical system that evolves over time as a set of its state recurrences. In this paper, RPs were extracted in order to identify the affected regions of the DMLN at very early stages of AD.

RESULTS

Using the RQA approach, we identified significant changes related to the AD phenotype at 4 m and/or 6 m in several areas of the rat DMLN including the BFB, Hippocampal fields CA1 and CA3, CG1, CG2, PrL, PtA, RSC, TeA, V1, V2. In addition, with age, brain activity of WT rats showed less predictability, while the AD rats presented reduced decline of predictability.

CONCLUSIONS

The results of this study demonstrate that RQA of rs-fMRI data is a potent approach that can detect subtle changes which might be missed by other methodologies due to the brain's non-linear dynamics. Moreover, this study provides helpful information about specific areas involved in AD pathology at very early stages of the disease in a very promising rat model of AD. Our results provide valuable information for the development of early detection methods and novel diagnosis tools for AD.

Advanced AI techniques for classifying Alzheimer's disease and mild cognitive impairment

Background

Alzheimer's disease and mild cognitive impairment are often difficult to differentiate due to their progressive nature and overlapping symptoms. The lack of reliable biomarkers further complicates early diagnosis. As the global population ages, the incidence of cognitive disorders increases, making the need for accurate diagnosis critical. Timely and precise diagnosis is essential for the effective treatment and intervention of these conditions. However, existing diagnostic methods frequently lead to a significant rate of misdiagnosis. This issue underscores the necessity for improved diagnostic techniques to better identify cognitive disorders in the aging population.

Methods

We used Graph Neural Networks, Multi-Layer Perceptrons, and Graph Attention Networks. GNNs map patient data into a graph structure, with nodes representing patients and edges shared clinical features, capturing key relationships. MLPs and GATs are used to analyse discrete data points for tasks such as classification and regression. Each model was evaluated on accuracy, precision, and recall.

Results

The AI models provide an objective basis for comparing patient data with reference populations. This approach enhances the ability to accurately distinguish between AD and MCI, offering more precise risk stratification and aiding in the development of personalized treatment strategies.

Conclusion

The incorporation of AI methodologies such as GNNs and MLPs into clinical settings holds promise for enhancing the diagnosis and management of Alzheimer's disease and mild cognitive impairment. By deploying these advanced computational techniques, clinicians could see a reduction in diagnostic errors, facilitating earlier, more precise interventions, and likely to lead to significantly improved outcomes for patients.

A hypergraph transformer method for brain disease diagnosis

Objective

To address the high-order correlation modeling and fusion challenges between functional and structural brain networks.

Method

This paper proposes a hypergraph transformer method for modeling high-order correlations between functional and structural brain networks. By utilizing hypergraphs, we can effectively capture the high-order correlations within brain networks. The Transformer model provides robust feature extraction and integration capabilities that are capable of handling complex multimodal brain imaging.

Results

The proposed method is evaluated on the ABIDE and ADNI datasets. It outperforms all the comparison methods, including traditional and graph-based methods, in diagnosing different types of brain diseases. The experimental results demonstrate its potential and application prospects in clinical practice.

Conclusion

The proposed method provides new tools and insights for brain disease diagnosis, improving accuracy and aiding in understanding complex brain network relationships, thus laying a foundation for future brain science research.

AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers - A narrative review of a growing field

OBJECTIVES

The objectives of this narrative review are to summarize the current state of AI applications in neuroimaging for early Alzheimer's disease (AD) prediction and to highlight the potential of AI techniques in improving early AD diagnosis, prognosis, and management.

METHODS

We conducted a narrative review of studies using AI techniques applied to neuroimaging data for early AD prediction. We examined single-modality studies using structural MRI and PET imaging, as well as multi-modality studies integrating multiple neuroimaging techniques and biomarkers. Furthermore, they reviewed longitudinal studies that model AD progression and identify individuals at risk of rapid decline.

RESULTS

Single-modality studies using structural MRI and PET imaging have demonstrated high accuracy in classifying AD and predicting progression from mild cognitive impairment (MCI) to AD. Multi-modality studies, integrating multiple neuroimaging techniques and biomarkers, have shown improved performance and robustness compared to single-modality approaches. Longitudinal studies have highlighted the value of AI in modeling AD progression and identifying individuals at risk of rapid decline. However, challenges remain in data standardization, model interpretability, generalizability, clinical integration, and ethical considerations.

CONCLUSION

AI techniques applied to neuroimaging data have the potential to improve early AD diagnosis, prognosis, and management. Addressing challenges related to data standardization, model interpretability, generalizability, clinical integration, and ethical considerations is crucial for realizing the full potential of AI in AD research and clinical practice. Collaborative efforts among researchers, clinicians, and regulatory agencies are needed to develop reliable, robust, and ethical AI tools that can benefit AD patients and society.

fMRI-based Alzheimer's disease detection via functional connectivity analysis: a systematic review

Alzheimer's disease is a common brain disorder affecting many people worldwide. It is the primary cause of dementia and memory loss. The early diagnosis of Alzheimer's disease is essential to provide timely care to AD patients and prevent the development of symptoms of this disease. Various non-invasive techniques can be utilized to diagnose Alzheimer's in its early stages. These techniques include functional magnetic resonance imaging, electroencephalography, positron emission tomography, and diffusion tensor imaging. They are mainly used to explore functional and structural connectivity of human brains. Functional connectivity is essential for understanding the co-activation of certain brain regions co-activation. This systematic review scrutinizes various works of Alzheimer's disease detection by analyzing the learning from functional connectivity of fMRI datasets that were published between 2018 and 2024. This work investigates the whole learning pipeline including data analysis, standard preprocessing phases of fMRI, feature computation, extraction and selection, and the various machine learning and deep learning algorithms that are used to predict the occurrence of Alzheimer's disease. Ultimately, the paper analyzed results on AD and highlighted future research directions in medical imaging. There is a need for an efficient and accurate way to detect AD to overcome the problems faced by patients in the early stages.

ERABiLNet: enhanced residual attention with bidirectional long short-term memory

Alzheimer's Disease (AD) causes slow death in brain cells due to shrinkage of brain cells which is more prevalent in older people. In most cases, the symptoms of AD are mistaken as age-related stresses. The most widely utilized method to detect AD is Magnetic Resonance Imaging (MRI). Along with Artificial Intelligence (AI) techniques, the efficacy of identifying diseases related to the brain has become easier. But, the identical phenotype makes it challenging to identify the disease from the neuro-images. Hence, a deep learning method to detect AD at the beginning stage is suggested in this work. The newly implemented "Enhanced Residual Attention with Bi-directional Long Short-Term Memory (Bi-LSTM) (ERABi-LNet)" is used in the detection phase to identify the AD from the MRI images. This model is used for enhancing the performance of the Alzheimer's detection in scale of 2-5%, minimizing the error rates, increasing the balance of the model, so that the multi-class problems are supported. At first, MRI images are given to "Residual Attention Network (RAN)", which is specially developed with three convolutional layers, namely atrous, dilated and Depth-Wise Separable (DWS), to obtain the relevant attributes. The most appropriate attributes are determined by these layers, and subjected to target-based fusion. Then the fused attributes are fed into the "Attention-based Bi-LSTM". The final outcome is obtained from this unit. The detection efficiency based on median is 26.37% and accuracy is 97.367% obtained by tuning the parameters in the ERABi-LNet with the help of Modified Search and Rescue Operations (MCDMR-SRO). The obtained results are compared with ROA-ERABi-LNet, EOO-ERABi-LNet, GTBO-ERABi-LNet and SRO-ERABi-LNet respectively. The ERABi_LNet thus provides enhanced accuracy and other performance metrics compared to such deep learning models. The proposed method has the better sensitivity, specificity, F1-Score and False Positive Rate compared with all the above mentioned competing models with values such as 97.49%.97.84%,97.74% and 2.616 respective;y. This ensures that the model has better learning capabilities and provides lesser false positives with balanced prediction.

Machine Learning and Graph Signal Processing Applied to Healthcare: A Review

Signal processing is a very useful field of study in the interpretation of signals in many everyday applications. In the case of applications with time-varying signals, one possibility is to consider them as graphs, so graph theory arises, which extends classical methods to the non-Euclidean domain. In addition, machine learning techniques have been widely used in pattern recognition activities in a wide variety of tasks, including health sciences. The objective of this work is to identify and analyze the papers in the literature that address the use of machine learning applied to graph signal processing in health sciences. A search was performed in four databases (Science Direct, IEEE Xplore, ACM, and MDPI), using search strings to identify papers that are in the scope of this review. Finally, 45 papers were included in the analysis, the first being published in 2015, which indicates an emerging area. Among the gaps found, we can mention the need for better clinical interpretability of the results obtained in the papers, that is not to restrict the results or conclusions simply to performance metrics. In addition, a possible research direction is the use of new transforms. It is also important to make new public datasets available that can be used to train the models.

A Cascaded Mutliresolution Ensemble Deep Learning Framework for Large Scale Alzheimer's Disease Detection Using Brain MRIs

Alzheimer's is progressive and irreversible type of dementia, which causes degeneration and death of cells and their connections in the brain. AD worsens over time and greatly impacts patients' life and affects their important mental functions, including thinking, the ability to carry on a conversation, and judgment and response to environment. Clinically, there is no single test to effectively diagnose Alzheimer disease. However, computed tomography (CT) and magnetic resonance imaging (MRI) scans can be used to help in AD diagnosis by observing critical changes in the size of different brain areas, typically parietal and temporal lobes areas. In this work, an integrative mulitresolutional ensemble deep learning-based framework is proposed to achieve better predictive performance for the diagnosis of Alzheimer disease. Unlike ResNet, DenseNet and their variants proposed pipeline utilizes PartialNet in a hierarchical design tailored to AD detection using brain MRIs. The advantage of the proposed analysis system is that PartialNet diversified the depth and deep supervision. Additionally, it also incorporates the properties of identity mappings which makes it powerful in better learning due to feature reuse. Besides, the proposed ensemble PartialNet is better in vanishing gradient, diminishing forward-flow with low number of parameters and better training time in comparison to its counter network. The proposed analysis pipeline has been tested and evaluated on benchmark ADNI dataset collected from 379 subjects patients. Quantitative validation of the obtained results documented our framework's capability, outperforming state-of-the-art learning approaches for both multi-and binary-class AD detection.

Ensemble Deep Random Vector Functional Link Network Using Privileged Information for Alzheimer's Disease Diagnosis

Alzheimer's disease (AD) is a progressive brain disorder. Machine learning models have been proposed for the diagnosis of AD at early stage. Recently, deep learning architectures have received quite a lot attention. Most of the deep learning architectures suffer from the issues of local minima, slow convergence and sensitivity to learning rate. To overcome these issues, non-iterative learning based deep randomized models especially random vector functional link network (RVFL) with direct links have proven to be successful. However, deep RVFL and its ensemble models are trained only on normal samples. In this paper, deep RVFL and its ensembles are enabled to incorporate privileged information, as the standard RVFL model and its deep models are unable to use privileged information. To fill this gap, we have incorporated learning using privileged information (LUPI) in deep RVFL model, and propose deep RVFL with LUPI framework (dRVFL+). Privileged information is available while training the models. As RVFL is an unstable classifier, we propose ensemble deep RVFL+ with LUPI framework (edRVFL+) which exploits the LUPI as well as the diversity among the base leaners for better classification. Unlike traditional ensemble approach wherein multiple base learners are trained, the proposed edRVFL+ model optimises a single network and generates an ensemble via optimization at different levels of random projections of the data. Both dRVFL+ and edRVFL+ efficiently utilise the privileged information which results in better generalization performance. In LUPI framework, half of the available features are used as normal features and rest as the privileged features. However, we propose a novel approach for generating the privileged information. We utilise different activation functions while processing the normal and privileged information in the proposed deep architectures. To the best of our knowledge, this is first time that a separate privileged information is generated. The proposed dRVFL+ and edRVFL+ models are employed for the diagnosis of Alzheimer's disease. Experimental results demonstrate the superiority of the proposed dRVFL+ and edRVFL+ models over baseline models. Thus, the proposed edRVFL+ model can be utilised in clinical setting for the diagnosis of AD.

Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping

Currently, numerous studies focus on employing fMRI-based deep neural networks to diagnose neurological disorders such as Alzheimer's Disease (AD), yet only a handful have provided results regarding explainability. We address this gap by applying several prevalent explainability methods such as gradient-weighted class activation mapping (Grad-CAM) to an fMRI-based 3D-VGG16 network for AD diagnosis to improve the model's explainability. The aim is to explore the specific Region of Interest (ROI) of brain the model primarily focuses on when making predictions, as well as whether there are differences in these ROIs between AD and normal controls (NCs). First, we utilized multiple resting-state functional activity maps including ALFF, fALFF, ReHo, and VMHC to reduce the complexity of fMRI data, which differed from many studies that utilized raw fMRI data. Compared to methods utilizing raw fMRI data, this manual feature extraction approach may potentially alleviate the model's burden. Subsequently, 3D-VGG16 were employed for AD classification, where the final fully connected layers were replaced with a Global Average Pooling (GAP) layer, aimed at mitigating overfitting while preserving spatial information within the feature maps. The model achieved a maximum of 96.4% accuracy on the test set. Finally, several 3D CAM methods were employed to interpret the models. In the explainability results of the models with relatively high accuracy, the highlighted ROIs were primarily located in the precuneus and the hippocampus for AD subjects, while the models focused on the entire brain for NC. This supports current research on ROIs involved in AD. We believe that explaining deep learning models would not only provide support for existing research on brain disorders, but also offer important referential recommendations for the study of currently unknown etiologies.

Spectral Graph Neural Network-Based Multi-Atlas Brain Network Fusion for Major Depressive Disorder Diagnosis

Major Depressive Disorder (MDD) imposes a substantial burden within the healthcare domain, impacting millions of individuals worldwide. Functional Magnetic Resonance Imaging (fMRI) has emerged as a promising tool for the objective diagnosis of MDD, enabling the investigation of functional connectivity patterns in the brain associated with this disorder. However, most existing methods focus on a single brain atlas, which limits their ability to capture the complex, multi-scale nature of functional brain networks. To address these limitations, we propose a novel multi-atlas fusion method that incorporates early and late fusion in a unified framework. Our method introduces the concept of the holistic Functional Connectivity Network (FCN), which captures both intra-atlas relationships within individual atlases and inter-regional relationships between atlases with different brain parcellation scales. This comprehensive representation enables the identification of potential disease-related patterns associated with MDD in the early stage of our framework. Moreover, by decoding the holistic FCN from various perspectives through multiple spectral Graph Convolutional Neural Networks and fusing their results with decision-level ensembles, we further improve the performance of MDD diagnosis. Our approach is easily implemented with minimal modifications to existing model structures and demonstrates a robust performance across different baseline models. Our method, evaluated on public resting-state fMRI datasets, surpasses the current multi-atlas fusion methods, enhancing the accuracy of MDD diagnosis. The proposed novel multi-atlas fusion framework provides a more reliable MDD diagnostic technique. Experimental results show our approach outperforms both single- and multi-atlas-based methods, demonstrating its effectiveness in advancing MDD diagnosis.

Intelligent decision support systems for dementia care: A scoping review

In the context of dementia care, Artificial Intelligence (AI) powered clinical decision support systems have the potential to enhance diagnosis and management. However, the scope and challenges of applying these technologies remain unclear. This scoping review aims to investigate the current state of AI applications in the development of intelligent decision support systems for dementia care. We conducted a comprehensive scoping review of empirical studies that utilised AI-powered clinical decision support systems in dementia care. The results indicate that AI applications in dementia care primarily focus on diagnosis, with limited attention to other aspects outlined in the World Health Organization (WHO) Global Action Plan on the Public Health Response to Dementia 2017-2025 (GAPD). A trifecta of challenges, encompassing data availability, cost considerations, and AI algorithm performance, emerges as noteworthy barriers in adoption of AI applications in dementia care. To address these challenges and enhance AI reliability, we propose a novel approach: a digital twin-based patient journey model. Future research should address identified gaps in GAPD action areas, navigate data-related obstacles, and explore the implementation of digital twins. Additionally, it is imperative to emphasize that addressing trust and combating the stigma associated with AI in healthcare should be a central focus of future research directions.

A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer's disease

BACKGROUND

Functional connectivity (FC) biomarkers play a crucial role in the early diagnosis and mechanistic study of Alzheimer's disease (AD). However, the identification of effective FC biomarkers remains challenging. In this study, we introduce a novel approach, the spatiotemporal graph convolutional network (ST-GCN) combined with the gradient-based class activation mapping (Grad-CAM) model (STGC-GCAM), to effectively identify FC biomarkers for AD.

METHODS

This multi-center cross-racial retrospective study involved 2,272 participants, including 1,105 cognitively normal (CN) subjects, 790 mild cognitive impairment (MCI) individuals, and 377 AD patients. All participants underwent functional magnetic resonance imaging (fMRI) and T1-weighted MRI scans. In this study, firstly, we optimized the STGC-GCAM model to enhance classification accuracy. Secondly, we identified novel AD-associated biomarkers using the optimized model. Thirdly, we validated the imaging biomarkers using Kaplan-Meier analysis. Lastly, we performed correlation analysis and causal mediation analysis to confirm the physiological significance of the identified biomarkers.

RESULTS

The STGC-GCAM model demonstrated great classification performance (The average area under the curve (AUC) values for different categories were: CN vs MCI = 0.98, CN vs AD = 0.95, MCI vs AD = 0.96, stable MCI vs progressive MCI = 0.79). Notably, the model identified specific brain regions, including the sensorimotor network (SMN), visual network (VN), and default mode network (DMN), as key differentiators between patients and CN individuals. These brain regions exhibited significant associations with the severity of cognitive impairment (p < 0.05). Moreover, the topological features of important brain regions demonstrated excellent predictive capability for the conversion from MCI to AD (Hazard ratio = 3.885, p < 0.001). Additionally, our findings revealed that the topological features of these brain regions mediated the impact of amyloid beta (Aβ) deposition (bootstrapped average causal mediation effect: β = -0.01 [-0.025, 0.00], p < 0.001) and brain glucose metabolism (bootstrapped average causal mediation effect: β = -0.02 [-0.04, -0.001], p < 0.001) on cognitive status.

CONCLUSIONS

This study presents the STGC-GCAM framework, which identifies FC biomarkers using a large multi-site fMRI dataset.

Towards privacy-preserving Alzheimer's disease classification: Federated learning on T1-weighted magnetic resonance imaging data

Objective

This study aims to address the challenge of privacy-preserving Alzheimer's disease classification using federated learning across various data distributions, focusing on real-world applicability. The goal is to improve the efficiency of classification by minimizing communication rounds between clients and the central server.

Methods

The proposed approach leverages two key strategies: increasing parallelism by utilizing more clients in each communication round and increasing computation per client during the intervals between rounds. To reflect real-world scenarios, data is divided into three distributions: identical and independently distributed, non-identical and independently distributed equal, and non-identical and independently distributed unequal. The impact of extreme quantity distribution skew is also examined. A convolutional neural network is used to evaluate the performance across these setups.

Results

The empirical study demonstrates that the proposed federated learning approach achieves a maximum accuracy of 84.75%, a precision of 86%, a recall of 85%, and an F1-score of 84%. Increasing the number of local epochs improves classification performance and reduces communication needs. The experiments show that federated learning is effective in handling heterogeneous datasets when all clients participate in each round of training. However, the results also indicate that extreme quantity distribution skew negatively impacts classification performance.

Conclusions

The study confirms that federated learning is a viable solution for Alzheimer's disease classification while preserving data privacy. Increasing local computation and client participation enhances classification performance, though extreme distribution imbalances present a challenge. Further investigation is needed to address these limitations in real-world scenarios.

Analyzing 20 years of Resting-State fMRI Research: Trends and collaborative networks revealed

Resting-state functional magnetic resonance imaging (rs-fMRI), initially proposed by Biswal et al. in 1995, has emerged as a pivotal facet of neuroimaging research. Its ability to examine brain activity during the resting state without the need for explicit tasks or stimuli has made it an integral component of brain imaging studies. In recent years, rs-fMRI has witnessed substantial growth and found widespread application in the investigation of functional connectivity within the brain. To delineate the developmental trajectory of rs-fMRI over the past two decades, we conducted a comprehensive analysis using bibliometric tool Citespace. Our analysis encompassed publication trends, authorship networks, institutional affiliations, international collaborations, as well as emergent themes in references and keywords. Our study reveals a remarkable increase in the volume of rs-fMRI publications over the past two decades, underscoring the burgeoning interest and potential within this field. Harvard University stands out as the institution with the highest number of research papers published in the realm of RS-fMRI, while the United States holds the highest overall influence in this domain. The recent emergence of keywords such as "machine learning" and "default mode," coupled with citation surges in reference to rs-fMRI, have paved new avenues for research within this field. Our study underscores the critical importance of integrating machine learning techniques into rs-fMRI investigations, offering valuable insights into brain function and disease diagnosis. These findings hold profound significance for the field of neuroscience and may furnish insights for future research employing rs-fMRI as a diagnostic tool for a wide array of neurological disorders, thus emphasizing its pivotal role and potential as a tool for investigating brain functionality.

Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties

BACKGROUND

Alzheimer's disease (AD) is characterized by neuroinflammation linked to amyloid β (Aβ) aggregation and phosphorylated tau (τ) protein in neurofibrillary tangles (NFTs). Key elements in Aβ production and NFT assembly, like γ-secretase and p38 mitogen-activated protein kinase (p38MAPK), contribute to neuroinflammation. In addition, impaired proteosomal and autophagic pathways increase Aβ and τ aggregation, leading to neuronal damage. Conventional neuroinflammation drugs have limitations due to unidirectional therapeutic approaches and challenges in crossing the Blood-Brain Barrier (BBB). Clinical trials for non-steroidal anti-inflammatory drugs (NSAIDs) and other therapeutics remain uncertain. Novel strategies addressing the complex pathogenesis and BBB translocation are needed to effectively tackle AD-related neuroinflammation.

PURPOSE

The current scenario demands for a much-sophisticated theranostic measures which could be achieved via customized engineering and designing of novel nanotherapeutics. As, these therapeutics functions as a double edge sword, having the efficiency of unambiguous targeting, multiple drug delivery and ability to cross BBB proficiently.

METHODS

Inclusion criteria involve selecting recent, English-language studies from the past decade (2013-2023) that explore the regulation of neuroinflammation in neuroinflammation, Alzheimer's disease, amyloid β, tau protein, nanoparticles, autophagy, and phytocompounds. Various study types, including clinical trials, experiments, and reviews, were considered. Exclusion criteria comprised non-relevant publication types, studies unrelated to Alzheimer's disease or phytocompounds, those with methodological flaws, duplicates, and studies with inaccessible data.

RESULTS

In this study, polymeric nanoparticles loaded with specific phytocompounds and coated with an antibody targeting the transferrin receptor (anti-TfR) present on BBB. Thereafter, the engineered nanoparticles with the ability to efficiently traverse the BBB and interact with target molecules within the brain, could induce autophagy, a cellular process crucial for neuronal health, and exhibit potent anti-inflammatory effects. Henceforth, the proposed combination of desired phytocompounds, polymeric nanoparticles, and anti-TfR coating presents a promising approach for targeted drug delivery to the brain, with potential implications in neuroinflammatory conditions such as Alzheimer's disease.

Neuroimaging-based classification of PTSD using data-driven computational approaches: A multisite big data study from the ENIGMA-PGC PTSD consortium

BACKGROUND

Recent advances in data-driven computational approaches have been helpful in devising tools to objectively diagnose psychiatric disorders. However, current machine learning studies limited to small homogeneous samples, different methodologies, and different imaging collection protocols, limit the ability to directly compare and generalize their results. Here we aimed to classify individuals with PTSD versus controls and assess the generalizability using a large heterogeneous brain datasets from the ENIGMA-PGC PTSD Working group.

METHODS

We analyzed brain MRI data from 3,477 structural-MRI; 2,495 resting state-fMRI; and 1,952 diffusion-MRI. First, we identified the brain features that best distinguish individuals with PTSD from controls using traditional machine learning methods. Second, we assessed the utility of the denoising variational autoencoder (DVAE) and evaluated its classification performance. Third, we assessed the generalizability and reproducibility of both models using leave-one-site-out cross-validation procedure for each modality.

RESULTS

We found lower performance in classifying PTSD vs. controls with data from over 20 sites (60 % test AUC for s-MRI, 59 % for rs-fMRI and 56 % for d-MRI), as compared to other studies run on single-site data. The performance increased when classifying PTSD from HC without trauma history in each modality (75 % AUC). The classification performance remained intact when applying the DVAE framework, which reduced the number of features. Finally, we found that the DVAE framework achieved better generalization to unseen datasets compared with the traditional machine learning frameworks, albeit performance was slightly above chance.

CONCLUSION

These results have the potential to provide a baseline classification performance for PTSD when using large scale neuroimaging datasets. Our findings show that the control group used can heavily affect classification performance. The DVAE framework provided better generalizability for the multi-site data. This may be more significant in clinical practice since the neuroimaging-based diagnostic DVAE classification models are much less site-specific, rendering them more generalizable.

Brain-guided manifold transferring to improve the performance of spiking neural networks in image classification

Spiking neural networks (SNNs), as the third generation of neural networks, are based on biological models of human brain neurons. In this work, a shallow SNN plays the role of an explicit image decoder in the image classification. An LSTM-based EEG encoder is used to construct the EEG-based feature space, which is a discriminative space in viewpoint of classification accuracy by SVM. Then, the visual feature vectors extracted from SNN is mapped to the EEG-based discriminative features space by manifold transferring based on mutual k-Nearest Neighbors (Mk-NN MT). This proposed "Brain-guided system" improves the separability of the SNN-based visual feature space. In the test phase, the spike patterns extracted by SNN from the input image is mapped to LSTM-based EEG feature space, and then classified without need for the EEG signals. The SNN-based image encoder is trained by the conversion method and the results are evaluated and compared with other training methods on the challenging small ImageNet-EEG dataset. Experimental results show that the proposed transferring the manifold of the SNN-based feature space to LSTM-based EEG feature space leads to 14.25% improvement at most in the accuracy of image classification. Thus, embedding SNN in the brain-guided system which is trained on a small set, improves its performance in image classification.

Autism spectrum disorder diagnosis based on deep unrolling-based spatial constraint representation

Accurate diagnosis of autism spectrum disorder (ASD) is crucial for effective treatment and prognosis. Functional brain networks (FBNs) constructed from functional magnetic resonance imaging (fMRI) have become a popular tool for ASD diagnosis. However, existing model-driven approaches used to construct FBNs lack the ability to capture potential non-linear relationships between data and labels. Moreover, most existing studies treat the FBNs construction and disease classification as separate steps, leading to large inter-subject variability in the estimated FBNs and reducing the statistical power of subsequent group comparison. To address these limitations, we propose a new approach to FBNs construction called the deep unrolling-based spatial constraint representation (DUSCR) model and integrate it with a convolutional classifier to create an end-to-end framework for ASD recognition. Specifically, the model spatial constraint representation (SCR) is solved using a proximal gradient descent algorithm, and we unroll it into deep networks using the deep unrolling algorithm. Classification is then performed using a convolutional prototype learning model. We evaluated the effectiveness of the proposed method on the ABIDE I dataset and observed a significant improvement in model performance and classification accuracy. The resting state fMRI images are preprocessed into time series data and 3D coordinates of each region of interest. The data are fed into the DUSCR model, a model for building functional brain networks using deep learning instead of traditional models, that we propose, and then the outputs are fed into the convolutional classifier with prototype learning to determine whether the patient has ASD disease.

Diagnosis of Alzheimer's Disease Based on Accelerated Mirror Descent Optimization and a Three-Dimensional Aggregated Residual Network

Alzheimer's disease (AD), a neuropsychiatric disorder, continually arises in the elderly. To date, no targeted medications have been developed for AD. Early and fast diagnosis of AD plays a pivotal role in identifying potential AD patients, enabling timely medical interventions, and mitigating disease progression. Computer-aided diagnosis (CAD) becomes possible with the burgeoning of deep learning. However, the existing CAD models for processing 3D Alzheimer's disease images usually have the problems of slow convergence, disappearance of gradient, and falling into local optimum. This makes the training of 3D diagnosis models need a lot of time, and the accuracy is often poor. In this paper, a novel 3D aggregated residual network with accelerated mirror descent optimization is proposed for diagnosing AD. First, a novel unbiased subgradient accelerated mirror descent (SAMD) optimization algorithm is proposed to speed up diagnosis network training. By optimizing the nonlinear projection process, our proposed algorithm can avoid the occurrence of the local optimum in the non-Euclidean distance metric. The most notable aspect is that, to the best of our knowledge, this is the pioneering attempt to optimize the AD diagnosis training process by improving the optimization algorithm. Then, we provide a rigorous proof of the SAMD's convergence, and the convergence of SAMD is better than any existing gradient descent algorithms. Finally, we use our proposed SAMD algorithm to train our proposed 3D aggregated residual network architecture (ARCNN). We employed the ADNI dataset to train ARCNN diagnostic models separately for the AD vs. NC task and the sMCI vs. pMCI task, followed by testing to evaluate the disease diagnostic outcomes. The results reveal that the accuracy can be improved in diagnosing AD, and the training speed can be accelerated. Our proposed method achieves 95.4% accuracy in AD diagnosis and 79.9% accuracy in MCI diagnosis; the best results contrasted with several state-of-the-art diagnosis methods. In addition, our proposed SAMD algorithm can save about 19% of the convergence time on average in the AD diagnosis model compared with the gradient descent algorithms, which is very momentous in clinic.

Deep Hashing Mutual Learning for Brain Network Classification

Recently, clinical phenotypic semantic information has begun to play an important role in some brain network classification methods based on deep learning. However, most current methods only consider the phenotypic semantic information of individual brain networks but ignore the potential phenotypic characteristics among group brain networks. To address this problem, we present a deep hashing mutual learning (DHML)-based brain network classification method. Specifically, we first design a separable CNN-based deep hashing learning to extract individual topological features of brain networks and map them into hash codes. Secondly, we construct a group brain network relationship graph based on the similarity of phenotypic semantic information, in which each node is a brain network, and the properties of the nodes are the individual features extracted in the previous step. Then, we adopt a GCN-based deep hashing learning to extract the group topological features of the brain network and map them to hash codes. Finally, the two deep hashing learning models perform mutual learning by measuring the distribution differences between the hash codes to achieve the interaction of individual and group features. The experimental results on the three commonly used brain atlases (AAL Atlas, Dosenbach160 Atlas, and CC200 Atlas) of the ABIDE I dataset show that our proposed DHML method achieves optimal classification performance compared with some state-of-the-art methods.

Multi-modal cross-attention network for Alzheimer's disease diagnosis with multi-modality data

Alzheimer's disease (AD) is a neurodegenerative disorder, the most common cause of dementia, so the accurate diagnosis of AD and its prodromal stage mild cognitive impairment (MCI) is significant. Recent studies have demonstrated that multiple neuroimaging and biological measures contain complementary information for diagnosis. Many existing multi-modal models based on deep learning simply concatenate each modality's features despite substantial differences in representation spaces. In this paper, we propose a novel multi-modal cross-attention AD diagnosis (MCAD) framework to learn the interaction between modalities for better playing their complementary roles for AD diagnosis with multi-modal data including structural magnetic resonance imaging (sMRI), fluorodeoxyglucose-positron emission tomography (FDG-PET) and cerebrospinal fluid (CSF) biomarkers. Specifically, the imaging and non-imaging representations are learned by the image encoder based on cascaded dilated convolutions and CSF encoder, respectively. Then, a multi-modal interaction module is introduced, which takes advantage of cross-modal attention to integrate imaging and non-imaging information and reinforce relationships between these modalities. Moreover, an extensive objective function is designed to reduce the discrepancy between modalities for effectively fusing the features of multi-modal data, which could further improve the diagnosis performance. We evaluate the effectiveness of our proposed method on the ADNI dataset, and the extensive experiments demonstrate that our MCAD achieves superior performance for multiple AD-related classification tasks, compared to several competing methods. Also, we investigate the importance of cross-attention and the contribution of each modality to the diagnostics performance. The experimental results demonstrate that combining multi-modality data via cross-attention is helpful for accurate AD diagnosis.

Classification of Alzheimer's Disease Using Maximal Information Coefficient-Based Functional Connectivity with an Extreme Learning Machine

Alzheimer's disease (AD) is a progressive chronic illness that leads to cognitive decline and dementia. Neuroimaging technologies, such as functional magnetic resonance imaging (fMRI), and deep learning approaches offer promising avenues for AD classification. In this study, we investigate the use of fMRI-based functional connectivity (FC) measures, including the Pearson correlation coefficient (PCC), maximal information coefficient (MIC), and extended maximal information coefficient (eMIC), combined with extreme learning machines (ELM) for AD classification. Our findings demonstrate that employing non-linear techniques, such as MIC and eMIC, as features for classification yields accurate results. Specifically, eMIC-based features achieve a high accuracy of 94% for classifying cognitively normal (CN) and mild cognitive impairment (MCI) individuals, outperforming PCC (81%) and MIC (85%). For MCI and AD classification, MIC achieves higher accuracy (81%) compared to PCC (58%) and eMIC (78%). In CN and AD classification, eMIC exhibits the best accuracy of 95% compared to MIC (90%) and PCC (87%). These results underscore the effectiveness of fMRI-based features derived from non-linear techniques in accurately differentiating AD and MCI individuals from CN individuals, emphasizing the potential of neuroimaging and machine learning methods for improving AD diagnosis and classification.

Ethical issues when using digital biomarkers and artificial intelligence for the early detection of dementia

Dementia poses a growing challenge for health services but remains stigmatized and under-recognized. Digital technologies to aid the earlier detection of dementia are approaching market. These include traditional cognitive screening tools presented on mobile devices, smartphone native applications, passive data collection from wearable, in-home and in-car sensors, as well as machine learning techniques applied to clinic and imaging data. It has been suggested that earlier detection and diagnosis may help patients plan for their future, achieve a better quality of life, and access clinical trials and possible future disease modifying treatments. In this review, we explore whether digital tools for the early detection of dementia can or should be deployed, by assessing them against the principles of ethical screening programs. We conclude that while the importance of dementia as a health problem is unquestionable, significant challenges remain. There is no available treatment which improves the prognosis of diagnosed disease. Progression from early-stage disease to dementia is neither given nor currently predictable. Available technologies are generally not both minimally invasive and highly accurate. Digital deployment risks exacerbating health inequalities due to biased training data and inequity in digital access. Finally, the acceptability of early dementia detection is not established, and resources would be needed to ensure follow-up and support for those flagged by any new system. We conclude that early dementia detection deployed at scale via digital technologies does not meet standards for a screening program and we offer recommendations for moving toward an ethical mode of implementation. This article is categorized under:Application Areas > Health CareCommercial, Legal, and Ethical Issues > Ethical ConsiderationsTechnologies > Artificial Intelligence.

A Survey on Brain Effective Connectivity Network Learning

Human brain effective connectivity characterizes the causal effects of neural activities among different brain regions. Studies of brain effective connectivity networks (ECNs) for different populations contribute significantly to the understanding of the pathological mechanism associated with neuropsychiatric diseases and facilitate finding new brain network imaging markers for the early diagnosis and evaluation for the treatment of cerebral diseases. A deeper understanding of brain ECNs also greatly promotes brain-inspired artificial intelligence (AI) research in the context of brain-like neural networks and machine learning. Thus, how to picture and grasp deeper features of brain ECNs from functional magnetic resonance imaging (fMRI) data is currently an important and active research area of the human brain connectome. In this survey, we first show some typical applications and analyze existing challenging problems in learning brain ECNs from fMRI data. Second, we give a taxonomy of ECN learning methods from the perspective of computational science and describe some representative methods in each category. Third, we summarize commonly used evaluation metrics and conduct a performance comparison of several typical algorithms both on simulated and real datasets. Finally, we present the prospects and references for researchers engaged in learning ECNs.

Application of TBSS-based machine learning models in the diagnosis of pediatric autism

Objective

To explore the microstructural changes of white matter in children with pediatric autism by using diffusion kurtosis imaging (DKI), and evaluate whether the combination of tract-based spatial statistics (TBSS) and back-propagation neural network (BPNN)/support vector machine (SVM)/logistic regression (LR) was feasible for the classification of pediatric autism.

Methods

DKI data were retrospectively collected from 32 children with autism and 27 healthy controls (HCs). Kurtosis fractional anisotropy (FAK), mean kurtosis (MK), axial kurtosis (KA), radial kurtosis (RK), fractional anisotropy (FA), axial diffusivity (DA), mean diffusivity (MD) and Radial diffusivity (DR) were generated by iQuant workstation. TBSS was used to detect the regions of parameters values abnormalities and for the comparison between these two groups. In addition, we also introduced the lateralization indices (LI) to study brain lateralization in children with pediatric autism, using TBSS for additional analysis. The parameters values of the differentiated regions from TBSS were then calculated for each participant and used as the features in SVM/BPNN/LR. All models were trained and tested with leave-one-out cross validation (LOOCV).

Results

Compared to the HCs group, the FAK, DA, and KA values of multi-fibers [such as the bilateral superior longitudinal fasciculus (SLF), corticospinal tract (CST) and anterior thalamic radiation (ATR)] were lower in pediatric autism group (p < 0.05, TFCE corrected). And we also found DA lateralization abnormality in Superior longitudinal fasciculus (SLF) (the LI in HCs group was higher than that in pediatric autism group). However, there were no significant differences in FA, MD, MK, DR, and KR values between HCs and pediatric autism group (P > 0.05, TFCE corrected). After performing LOOCV to train and test three model (SVM/BPNN/LR), we found the accuracy of BPNN (accuracy = 86.44%) was higher than that of LR (accuracy = 76.27%), but no different from SVM (RBF, accuracy = 81.36%; linear, accuracy = 84.75%).

Conclusion

Our proposed method combining TBSS findings with machine learning (LR/SVM/BPNN), was applicable in the classification of pediatric autism with high accuracy. Furthermore, the FAK, DA, and KA values and Lateralization index (LI) value could be used as neuroimaging biomarkers to discriminate the children with pediatric autism or not.

CAD-ALZ: A Blockwise Fine-Tuning Strategy on Convolutional Model and Random Forest Classifier for Recognition of Multistage Alzheimer's Disease

Mental deterioration or Alzheimer's (ALZ) disease is progressive and causes both physical and mental dependency. There is a need for a computer-aided diagnosis (CAD) system that can help doctors make an immediate decision. (1) Background: Currently, CAD systems are developed based on hand-crafted features, machine learning (ML), and deep learning (DL) techniques. Those CAD systems frequently require domain-expert knowledge and massive datasets to extract deep features or model training, which causes problems with class imbalance and overfitting. Additionally, there are still manual approaches used by radiologists due to the lack of dataset availability and to train the model with cost-effective computation. Existing works rely on performance improvement by neglecting the problems of the limited dataset, high computational complexity, and unavailability of lightweight and efficient feature descriptors. (2) Methods: To address these issues, a new approach, CAD-ALZ, is developed by extracting deep features through a ConvMixer layer with a blockwise fine-tuning strategy on a very small original dataset. At first, we apply the data augmentation method to images to increase the size of datasets. In this study, a blockwise fine-tuning strategy is employed on the ConvMixer model to detect robust features. Afterwards, a random forest (RF) is used to classify ALZ disease stages. (3) Results: The proposed CAD-ALZ model obtained significant results by using six evaluation metrics such as the F1-score, Kappa, accuracy, precision, sensitivity, and specificity. The CAD-ALZ model performed with a sensitivity of 99.69% and an F1-score of 99.61%. (4) Conclusions: The suggested CAD-ALZ approach is a potential technique for clinical use and computational efficiency compared to state-of-the-art approaches. The CAD-ALZ model code is freely available on GitHub for the scientific community.

Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review

Alzheimer's disease (AD) is currently diagnosed using a mixture of psychological tests and clinical observations. However, these diagnoses are not perfect, and additional diagnostic tools (e.g., MRI) can help improve our understanding of AD as well as our ability to detect the disease. Accordingly, a large amount of research has been invested into innovative diagnostic methods for AD. Functional MRI (fMRI) is a form of neuroimaging technology that has been used to diagnose AD; however, fMRI is incredibly noisy, complex, and thus lacks clinical use. Nonetheless, recent innovations in deep learning technology could enable the simplified and streamlined analysis of fMRI. Deep learning is a form of artificial intelligence that uses computer algorithms based on human neural networks to solve complex problems. For example, in fMRI research, deep learning models can automatically denoise images and classify AD by detecting patterns in participants' brain scans. In this systematic review, we investigate how fMRI (specifically resting-state fMRI) and deep learning methods are used to diagnose AD. In turn, we outline the common deep neural network, preprocessing, and classification methods used in the literature. We also discuss the accuracy, strengths, limitations, and future direction of fMRI deep learning methods. In turn, we aim to summarize the current field for new researchers, suggest specific areas for future research, and highlight the potential of fMRI to aid AD diagnoses.

Multi-label classification of Alzheimer's disease stages from resting-state fMRI-based correlation connectivity data and deep learning

Alzheimer's disease is a neurodegenerative condition that gradually impairs cognitive abilities. Recently, various neuroimaging modalities and machine learning methods have surfaced to diagnose Alzheimer's disease. Resting-state fMRI is a neuroimaging modality that has been widely utilized to study brain activity related to neurodegenerative diseases. In literature, the previous studies are limited to the binary classification of Alzheimer's disease and Mild Cognitive Impairment. The application of computer-aided diagnosis for the numerous advancing phases of Alzheimer's disease, on the other hand, remains understudied. This research analyzes and presents methods for multi-label classification of six Alzheimer's stages using rs-fMRI and deep learning. The proposed model solves the multi-class classification problem by extracting the brain's functional connectivity networks from rs-fMRI data and employing two deep learning approaches, Stacked Sparse Autoencoder and Brain Connectivity Graph Convolutional Network. The suggested models' results were assessed using the k-fold cross-validation approach, and an average accuracy of 77.13% and 84.03% was reached for multi-label classification using Stacked Sparse Autoencoders and Brain Connectivity Based Convolutional Network, respectively. An analysis of brain regions was also performed by using the network's learned weights, leading to the conclusion that the precentral gyrus, frontal gyrus, lingual gyrus, and supplementary motor area are the significant brain regions of interest.

An efficient Alzheimer's disease prediction based on MEPC-SSC segmentation and momentum geo-transient MLPs

A decline in cognitive functioning of the brain termed Alzheimer's Disease (AD) is an irremediable progressive brain disorder, which has no corroborated disease-modifying treatment. Therefore, to slow or avoid disease progression, a greater endeavour has been made to develop techniques for earlier detection, particularly at pre-symptomatic stages. To predict AD, several strategies have been developed. Nevertheless, it is still challenging to predict AD by classifying them into AD, Mild Cognitive Impairment (MCI), along with Normal Control (NC) regarding larger features. By utilizing the Momentum Golden Eagle Optimizer-centric Transient Multi-Layer Perceptron network (Momentum GEO-Transient MLP), an effectual AD prediction technique has been proposed to trounce the aforementioned issues. Firstly, the input images are supplied for post-processing. In post-processing, by employing Patch Wise L1 Norm (PWL1N), the image resizing along with noise removal is engendered. Then, by utilizing Truncate Intensity Based Operation (TIBO) from the post-processed images, the unwanted brain parts are taken away. Next, the skull-stripped images are pre-processed. In this, by deploying Carnot Cycle Entropy-centric Global and Local technique (c2EBGAL), the images are normalized along with ameliorated. Afterward, by implementing Modified Emperor Penguins Colony-centered Sparse Subspace Clustering (MEPC-SSC), the pre-processed images are segmented. Then, for extracting the features, the segmented images are utilized; subsequently, the features being extracted are fed to the Momentum GEO-Transient MLPs.For transferring images fromMRI into more compact higher-level features, this system is wielded for fusing features from diverse layers. The parameters, which minimize the computation complexity, are decreased. For AD classification, the proposed technique is analogized to the prevailing methodologies regardingaccuracy, sensitivity, specificity et cetera along with acquired enhanced outcomes. Thus, the proposed system is apt for the AD diagnosis.

The complexity of spontaneous brain activity changes in schizophrenia, bipolar disorder, and ADHD was examined using different variations of entropy

Adult attention deficit/hyperactivity disorder (ADHD), schizophrenia (SCHZ), and bipolar disorder (BP) have common symptoms and differences, and the underlying neural mechanisms are still unclear. This article will thoroughly discuss the differences between ADHD, BP, and SCHZ (31 healthy control and 31 ADHD; 34 healthy control and 34 BP; 42 healthy control and 42 SCHZ) relative to healthy subjects in combination with three atlases (et al., the Brainnetome atlas, the Dosenbach atlas, the Power atlas) and seven entropies (et al., approximate entropy (ApEn), sample entropy (SaEn), permutation entropy (PeEn), fuzzy entropy (FuEn), differential entropy (DiffEn), range entropy (RaEn), and dispersion entropy (DispEn)), as well as the prominent significant brain regions, in the hope of giving information that is more suitable for analyzing different diseases' entropy. First, the reliability (et al., intraclass correlation coefficient [ICC]) of seven kinds of entropy is calculated and analyzed by using the MSC dataset (10 subjects and 100 sessions in total) and simulation data; then, seven types of entropy and multiscale entropy expanded based on seven kinds of entropy are used to explore the differences and brain regions of ADHD, BP, and SCHZ relative to healthy subjects; and finally, by verifying the classification performance of the seven information entropies on ADHD, BP, and SCHZ, the effectiveness of the seven entropy methods is evaluated through these three methods. The core brain regions that affect the classification are given, and DiffEn performed best on ADHD, SaEn for BP, and RaEn for SCHZ.

Inherent regional brain activity changes in male obstructive sleep apnea with mild cognitive impairment: A resting-state magnetic resonance study

Obstructive sleep apnea (OSA) is the most common sleep disorder worldwide. Previous studies have shown that OSA patients are often accompanied by cognitive function loss, and the underlying neurophysiological mechanism is still unclear. This study aimed to determine whether there are differences in regional homogeneity (Reho) and functional connectivity (FC) across the brain between OSA patients with MCI (OSA-MCI) and those without MCI (OSA-nMCI) and whether such differences can be used to distinguish the two groups. Resting state magnetic resonance data were collected from 48 OSA-MCI patients and 47 OSA-nMCI patients. The brain regions with significant differences in Reho and FC between the two groups were identified, and the Reho and FC features were combined with machine learning methods for classification. Compared with OSA-nMCI patients, OSA-MCI patients showed significantly lower Reho in bilateral lingual gyrus and left superior temporal gyrus. OSA-MCI patients also showed significantly lower FC between the bilateral lingual gyrus and bilateral cuneus, left superior temporal gyrus and left middle temporal gyrus, middle frontal gyrus, and bilateral posterior cingulate/calcarine/cerebellar anterior lobe. Based on Reho and FC features, logistic regression classification accuracy was 0.87; sensitivity, 0.70; specificity, 0.89; and area under the curve, 0.85. Correlation analysis showed that MoCA scale score in OSA patients was significant positive correlation sleep efficiency and negatively correlation with neck circumference. In conclusion, our results showed that the OSA-MCI group showed decreased Reho and FC in specific brain regions compared with the OSA-nMCI group, which may help to understand the underlying neuroimaging mechanism of OSA leading to cognitive dysfunction and may serve as a potential biomarker to distinguish whether OSA is accompanied by cognitive impairment.

A Multiview Deep Learning Method for Brain Functional Connectivity Classification

The brain functional connectivity classification based on deep learning is a research hotspot nowadays. However, the classification performance is far behind the demand of clinical applications. To alleviate the problem, this paper proposes a multiview deep learning method for brain functional connectivity classification. Firstly, the proposed method adopts multiple brain atlases to identify brain regions and thereby builds different brain functional connectivity of different views. Secondly, it uses a multiview feature selection strategy to select out the most discriminative features of each view with the assistance of other views. Then, it trains a stacked autoencoder to extract deep features of the brain functional connectivity of each view. At last, it utilizes a multiview fusion strategy to take full advantage of complementary information of different views for brain functional connectivity classification. The proposed method has been compared with several deep learning-based brain functional connectivity classification methods on three public datasets of neuropsychiatric disorders. The experimental results have validated the superior performance of the proposed method.

Functional Brain Network Classification Based on Deep Graph Hashing Learning

Brain network classification using resting-state functional magnetic resonance imaging (rs-fMRI) is an effective analytical method for diagnosing brain diseases. In recent years, brain network classification methods based on deep learning have attracted increasing attention. However, these methods only consider the spatial topological characteristics of the brain network but ignore its proximity relationships in semantic space. To overcome this problem, we propose a novel brain network classification method based on deep graph hashing learning named BNC-DGHL. Specifically, we first extract the deep features of the brain network and then learn a graph hash function based on clinical phenotype labels and the similarity of diagnostic labels. Secondly, we use the learned graph hash function to convert deep features into hash codes, which can maintain the original semantic spatial relationships. Finally, we calculate the distance between hash codes to obtain the predicted category of the brain network. Experimental results on ABIDE I, ABIDE II, and ADHD-200 datasets demonstrate that our method achieves better classification performance of brain diseases compared with some state-of-the-art methods, and the abnormal functional connectivities between brain regions identified may serve as biomarkers associated with related brain diseases.

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning

The combination and integration of multimodal imaging and clinical markers have introduced numerous classifiers to improve diagnostic accuracy in detecting and predicting AD; however, many studies cannot ensure the homogeneity of data sets and consistency of results. In our study, the XGBoost algorithm was used to classify mild cognitive impairment (MCI) and normal control (NC) populations through five rs-fMRI analysis datasets. Shapley Additive exPlanations (SHAP) is used to analyze the interpretability of the model. The highest accuracy for diagnosing MCI was 65.14% (using the mPerAF dataset). The characteristics of the left insula, right middle frontal gyrus, and right cuneus correlated positively with the output value using DC datasets. The characteristics of left cerebellum 6, right inferior frontal gyrus, opercular part, and vermis 6 correlated positively with the output value using fALFF datasets. The characteristics of the right middle temporal gyrus, left middle temporal gyrus, left temporal pole, and middle temporal gyrus correlated positively with the output value using mPerAF datasets. The characteristics of the right middle temporal gyrus, left middle temporal gyrus, and left hippocampus correlated positively with the output value using PerAF datasets. The characteristics of left cerebellum 9, vermis 9, and right precentral gyrus, right amygdala, and left middle occipital gyrus correlated positively with the output value using Wavelet-ALFF datasets. We found that the XGBoost algorithm constructed from rs-fMRI data is effective for the diagnosis and classification of MCI. The accuracy rates obtained by different rs-fMRI data analysis methods are similar, but the important features are different and involve multiple brain regions, which suggests that MCI may have a negative impact on brain function.

Convolutional Recurrent Neural Network for Dynamic Functional MRI Analysis and Brain Disease Identification

Dynamic functional connectivity (dFC) networks derived from resting-state functional magnetic resonance imaging (rs-fMRI) help us understand fundamental dynamic characteristics of human brains, thereby providing an efficient solution for automated identification of brain diseases, such as Alzheimer's disease (AD) and its prodromal stage. Existing studies have applied deep learning methods to dFC network analysis and achieved good performance compared with traditional machine learning methods. However, they seldom take advantage of sequential information conveyed in dFC networks that could be informative to improve the diagnosis performance. In this paper, we propose a convolutional recurrent neural network (CRNN) for automated brain disease classification with rs-fMRI data. Specifically, we first construct dFC networks from rs-fMRI data using a sliding window strategy. Then, we employ three convolutional layers and long short-term memory (LSTM) layer to extract high-level features of dFC networks and also preserve the sequential information of extracted features, followed by three fully connected layers for brain disease classification. Experimental results on 174 subjects with 563 rs-fMRI scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) demonstrate the effectiveness of our proposed method in binary and multi-category classification tasks.

End-to-End Deep Learning Architectures Using 3D Neuroimaging Biomarkers for Early Alzheimer’s Diagnosis

This study uses magnetic resonance imaging (MRI) data to propose end-to-end learning implementing volumetric convolutional neural network (CNN) models for two binary classification tasks: Alzheimer’s disease (AD) vs. cognitively normal (CN) and stable mild cognitive impairment (sMCI) vs. AD. The baseline MP-RAGE T1 MR images of 245 AD patients and 229 with sMCI were obtained from the ADNI dataset, whereas 245 T1 MR images of CN people were obtained from the IXI dataset. All of the images were preprocessed in four steps: N4 bias field correction, denoising, brain extraction, and registration. End-to-end-learning-based deep CNNs were used to discern between different phases of AD. Eight CNN-based architectures were implemented and assessed. The DenseNet264 excelled in both types of classification, with 82.5% accuracy and 87.63% AUC for training and 81.03% accuracy for testing relating to the sMCI vs. AD and 100% accuracy and 100% AUC for training and 99.56% accuracy for testing relating to the AD vs. CN. Deep learning approaches based on CNN and end-to-end learning offer a strong tool for examining minute but complex properties in MR images which could aid in the early detection and prediction of Alzheimer’s disease in clinical settings.

A Hierarchical Graph Learning Model for Brain Network Regression Analysis

Brain networks have attracted increasing attention due to the potential to better characterize brain dynamics and abnormalities in neurological and psychiatric conditions. Recent years have witnessed enormous successes in deep learning. Many AI algorithms, especially graph learning methods, have been proposed to analyze brain networks. An important issue for existing graph learning methods is that those models are not typically easy to interpret. In this study, we proposed an interpretable graph learning model for brain network regression analysis. We applied this new framework on the subjects from Human Connectome Project (HCP) for predicting multiple Adult Self-Report (ASR) scores. We also use one of the ASR scores as the example to demonstrate how to identify sex differences in the regression process using our model. In comparison with other state-of-the-art methods, our results clearly demonstrate the superiority of our new model in effectiveness, fairness, and transparency.

A semi-supervised classification RBM with an improved fMRI representation algorithm

BACKGROUND AND OBJECTIVE

Training an effective and robust supervised learning classifier is not easy due to the limitations of acquiring and labeling considerable human functional magnetic resonance imaging (fMRI) data. Semi-supervised learning uses unlabeled data for feature learning and combines them into labeled data to build better classification models.

METHODS

Since no premises or assumptions are required, a restricted Boltzmann machine (RBM) is suitable for learning data representation of neuroimages. In our study, an improved fMRI representation algorithm with a hybrid L1/L2 regularization method (HRBM) was proposed to optimize the original model for sparsity. Different from common semi-supervised classification models that treat feature learning and classification as two separate training steps, we then constructed a new semi-supervised classification RBM based on a joint training algorithm with HRBM, named Semi-HRBM. This joint training algorithm jointly trains the objective function of feature learning and classification process, so that the learned features can effectively represent the original fMRI data and adapt to the classification tasks.

RESULTS

This study uses fMRI data to identify categories of visual stimuli. In the fMRI data classification task under four visual stimuli (house, face, car, and cat), our HRBM has satisfactory feature representation capabilities and better performance for multiple classification tasks. Taking the supervised RBM (sup-RBM) as an example, our Semi-HRBM classification model improves the average accuracy of the four-classification task by 7.68%, and improves the average F1 score of each visual stimulus task by 8.90%. In addition, the generalization ability of the model was also improved.

CONCLUSION

This research might contribute to enrich solutions for insufficiently labeled neuroimaging samples, which could help to identify complex brain states under different stimuli or tasks.